<VariationArchive RecordType="classified" VariationID="989470" VariationName="NM_001035.2(RYR2):c.(?_169)_(273_?)del (p.(?))" VariationType="Deletion" Accession="VCV000989470" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2017-04-16" MostRecentSubmission="2017-04-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="977408" VariationID="989470">
      <GeneList>
        <Gene Symbol="RYR2" FullName="ryanodine receptor 2" GeneID="6262" HGNC_ID="HGNC:10484" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="237042184" stop="237833988" display_start="237042184" display_stop="237833988" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="237205701" stop="237997287" display_start="237205701" display_stop="237997287" Strand="+" />
          </Location>
          <OMIM>180902</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001035.2(RYR2):c.(?_169)_(273_?)del (p.(?))</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q43</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="237494178" innerStop="237494282" display_start="237494178" display_stop="237494282" variantLength="105" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_237494178)_(237494282_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_237494178)_(237494282_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001035.2(RYR2):c.(?_169)_(273_?)del (p.(?)) AND Catecholaminergic polymorphic ventricular tachycardia" Accession="RCV001271104" Version="2">
        <ClassifiedConditionList TraitSetID="21630">
          <ClassifiedCondition DB="MedGen" ID="C5574922">Catecholaminergic polymorphic ventricular tachycardia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-01-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-04-16" MostRecentSubmission="2017-04-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="21630" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia</ElementValue>
                <XRef ID="MONDO:0017990" DB="MONDO" />
                <XRef ID="3286" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Catecholamine-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polymorphic catecholergic ventricular tachycardia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CVPT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4421" />
                <XRef ID="4421" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C5574922" DB="MedGen" />
              <XRef ID="MONDO:0017990" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS604772" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="578604" SubmissionDate="2017-03-14" DateLastUpdated="2017-04-16" DateCreated="2016-09-04">
        <ClinVarSubmissionID localKey="1138900|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000299146" DateUpdated="2017-04-16" DateCreated="2016-09-04" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon 3 of the RYR2 gene. This leads to an in-frame deletion, preserving the integrity of the reading frame. Deletions that encompass exon 3 of the RYR2 gene have been reported in the literature in individuals affected with noncompaction cardiomyopathy and catecholaminergic polymorphic ventricular tachycardia and have been shown to segregate with the disease in the families analyzed (PMID: 17875969, 19216760, 19926015, 23479668, 24394973, 25835811, 26018045). Experimental studies have shown that this in-frame deletion changes the channel properties of RYR2 by markedly reducing the luminal Ca2+ threshold at which Ca2+ release terminates (PMID: 22374134). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_237494178)_(237494282_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016June_Corrections</SubmissionName>
          <SubmissionName>2017March_Invitae</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="578604" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

